In vitro and in vivo evaluation of camptothecin nanosuspension: A novel formulation with high antitumor efficacy and low toxicity

International Journal of Pharmaceutics

Volumn 423, Issue 2, 2012, Pages 586-588

  Yao, Liping ^a   Zhao, Xiuhua ^a   Li, Qingyong ^a   Zu, Yuangang ^a   Fu, Yujie ^a   Zu, Baishi ^a   Meng, Xiangdong ^a   Liu, Chen ^a  

^a NORTHEAST FORESTRY UNIVERSITY   (China)

Author keywords

Antitumor activity; Camptothecin nanosuspension; Cytotoxicity; Dose dependent toxicity; Topotecan

Indexed keywords

CAMPTOTHECIN; NANOPARTICLE; TOPOTECAN;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; BODY WEIGHT; CANCER INHIBITION; CELL LINE; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; REVIEW; SUSPENSION; TUMOR XENOGRAFT;

EID: 84856530789     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.11.031     Document Type: Article

References (13)

1. S.S. Adkins, H.R. Hobbs, K. Benaissi, K.P. Johnston, M. Poliakoff, and N.R. Thomas Stable colloidal dispersions of a lipaseperfluoropolyether complex in liquid and supercritical carbon dioxide J. Phys. Chem. B 112 2008 4760 4769
2. J. Cortes, A.M. Tsimberidou, R. Alvarez, D. Thomas, M. Beran, H. Kantarjian, E. Estey, and J.F. Giles Mylotarg combined with topotecan and cytarabine in patients with refractory acute myelogenous leukemia Cancer Chemother. Pharmacol. 50 2002 497 500 (Pubitemid 35435529)
3. R. Cortesi, E. Esposito, A. Maietti, E. Menegatti, and C. Nastruzzi Formulation study for the antitumor drug camptothecin: liposomes, micellar solutions and a microemulsion Int. J. Pharm. 159 1997 95 103 (Pubitemid 28062814)
4. K. Inoue, E. Kumazawa, H. Kuga, H. Susaki, N. Masubuchi, and T. Kajimura CMdextran-polyalcohol-camptothecin conjugate: DE-310 with a novel carrier system and its preclinical data Adv. Exp. Med. Biol. 519 2003 145 153 (Pubitemid 36577705)
5. J.C. Kang, V. Kumar, D. Yang, P.R. Chowdhury, and R.J. Hohl Cyclodextrin complexation: influence on the solubility, stability, and cytotoxicity of camptothecin, an antineoplastic agent Eur. J. Pharm. Sci. 15 2002 163 170 (Pubitemid 34155378)
6. C. Moon, Y.M. Kwon, W.K. Lee, Y.J. Park, L.C. Chang, and V.C. Yang A novel polyrotaxane-based intracellular delivery system for camptothecin: in vitro feasibility evaluation J. Biomed. Mater. Res. A 84A 2008 238 246 (Pubitemid 350244265)
7. J. Moschwitzer, G. Achleitner, H. Pomper, and R.H. Müller Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology Eur. J. Pharm. Biopharm. 58 2004 615 619 (Pubitemid 39297108)
8. R.H. Müller, S. Gohla, and C.M. Keck State of the art of nanocrystals - special features, production, nanotoxicology aspects and intracellular delivery Eur. J. Pharm. Biopharm. 78 2011 1 9
9. N.H. Oberlies, and D.J. Kroll Camptothecin and taxol: historic achievements in natural products research J. Nat. Prod. 67 2004 129 135 (Pubitemid 38282896)
10. N. Saijo Clinical trials of irinotecan hydrochloride in Japan Ann. N.Y. Acad. Sci. 803 1996 292 305
11. T. Schneider, H. Zhao, J.K. Jackson, G.H. Chapman, J. Dykes, and U.O. Häfeli Use of hydrodynamic flow focusing for the generation of biodegradable camptothecin-loaded polymer microspheres J. Pharm. Sci. 97 2008 4943 4954
12. M.E. Wall, B.C. Giovanella, and J.S. Stehlin DNA topoisomerase I-targeted chemotherapy of human colon cancer in xenografts Science 246 1989 1046 1048 (Pubitemid 20010531)
13. X.H. Zhao, Y.G. Zu, Q.Y. Li, M.X. Wang, B.S. Zu, X.N. Zhang, R. Jiang, and C.L. Zu Preparation and characterization of camptothecin powder micronized by a supercritical antisolvent (SAS) process J. Supercrit. Fluids 51 2010 412 419